Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. 

Biotechnology

Ocugen

Ocugen's headquarters in Malvern, PA, United States

Shankar Musunuri

Ramesh Ramachandran

Abhishek Gupta

Kristen Craft

Tiffany J. Hamilton

Jyothy Pillai

Arun Upadhyay

Carl D. Regillo

David Fajgenbaum

Bruce D. Forrest

Susan Weiss

Pat Toomey

Joseph W. Westphal

Dennis Carey

Geeta Lalwani

Kirsten M. Castillo

David Boyer

Satish Chandran

Marna C. Whittington

Uday Kompella

Catherine Pachuk

Prabhavathi Fernandes

Junge Zhang

Mark Pennesi

Harvey Rubin

The Scientific Advisory Team at Ocugen is responsible for providing expert guidance on the scientific and technical aspects of gene therapy research and development. Composed of experienced scientific advisors and a senior scientist, the team evaluates research strategies, reviews data, and ensures alignment with industry standards, ultimately supporting the advancement of innovative treatments for blindness diseases and contributing to vaccine development efforts.

Scientific Advisory Team

The Leadership Team at Ocugen drives the strategic vision and operational direction of the company, focusing on innovation in gene therapies for blindness and vaccine development. Comprising top executives with expertise in science, research, and commercial strategy, the team collaborates to advance Ocugen's mission and ensure successful product development and market introduction while navigating regulatory landscapes.

Leadership Team

The Finance and Administration Team at Ocugen is responsible for overseeing the company's financial health and strategic planning. This includes managing budgets, financial reporting, and compliance, as well as streamlining administrative processes to ensure efficient operations. By providing critical financial insights, this team supports Ocugen’s mission to innovate in gene therapies and vaccine development.

Finance and Administration Team

The Regulatory and Compliance Team at Ocugen is responsible for ensuring that all biopharmaceutical products meet industry regulations and quality standards throughout their development and commercialization. This includes managing regulatory submissions, overseeing clinical trials to ensure adherence to protocols, and implementing quality assurance measures to support the safe and effective use of gene therapies and vaccines. Their efforts are critical to securing regulatory approvals and maintaining compliance with health authorities.

Regulatory and Compliance Team

Ocugen

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Finance and Administration Team

Regulatory and Compliance Team

Offices

Ocugen

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Finance and Administration Team

Regulatory and Compliance Team

Offices

Related companies